DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 6.17% to $738.34 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.66% to 7,437.63 and the Dow Jones Industrial Average rising 1.19% to 52,208.06.
This was the stock's sixth consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 10.08% below its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. $(AMGN)$ remained unchanged, Moderna Inc. (MRNA) rose 6.29% to $57.92, and Gilead Sciences Inc. (GILD) fell 1.09% to $131.28.
Trading volume (1.5 M) eclipsed its 50-day average volume of 1.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026.
Comments